Literature DB >> 4164258

Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.

C D West, S Winter, J Forristal, J M McConville, N C Davis.   

Abstract

Evidence has been obtained for the presence in vivo of alpha(2D)-globulin, a breakdown product of serum beta(1C)-globulin, in patients with acute and persistent hypocomplementemic glomerulonephritis. The protein has been identified by immunoelectrophoretic analysis, and the amounts present have been determined by direct measurement of specific antigenic determinants present on alpha(2D). beta(1A)-Globulin, another breakdown product of beta(1C)-globulin, may also be present in vivo in severely hypocomplementemic patients, but its levels are much lower than those of alpha(2D)-globulin.Alpha(2D)-globulin has been identified by immunoelectrophoretic analysis of fresh EDTA plasma from patients with hypocomplementemic nephritis as an arc in the alpha(2) region that shows a reaction of identity with the arc representing alpha(2D)-globulin produced by aged normal serum. beta(1A)-Globulin was not seen in these patterns. Measurement of specific antigenic determinants has been carried out in both fresh EDTA plasma and aged serum. In the fresh plasma, the concentration of D antigen, found on both beta(1C)- and alpha(2D)-globulins, has been related to that of B antigen, found only on beta(1C) and taken as a measure of the concentration of this protein. In the hypocomplementemic patients, the concentration of D antigen, in comparison to that of B, was greater than in the normal subjects. Similarly, in aged serum, the level of alpha(2D) was greater than would be expected from the amount of beta(1C) that had been broken down in vitro, measured by the concentration of beta(1A). Calculations indicated that the in vivo alpha(2D) level in severely hypocomplementemic patients ranged from 7.5 to 18% of that which would be found in a pool of aged normal serum in which beta(1C) is completely broken down. The levels tended to be lower in less severely hypocomplementemic patients, and none could be detected in normal plasma. Only small quantities of A and D antigens are detectable in the urine of patients with hypocomplementemic nephritis. The rate of excretion is about equal to that of the normal subject. The study indicates that the low serum levels of beta(1C)-globulin that may be present over long periods in patients with persistent hypocomplementemic glomerulonephritis can be ascribed, in part, to in vivo breakdown of this protein as a result of reaction with immune complexes. The contribution of beta(1C) deposition on immune complexes and of diminished synthesis to the depressed serum levels cannot be assessed by the present study.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4164258      PMCID: PMC442037          DOI: 10.1172/JCI105555

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  8 in total

1.  SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

Authors:  C D WEST; J D NORTHWAY; N C DAVIS
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  THE BETA-1C GLOBULIN IN CHILDHOOD NEPHROTIC SYNDROME: LABORATORY DIAGNOSIS OF PROGRESSIVE GLOMERULONEPHRITIS.

Authors:  S P GOTOFF; F X FELLERS; G F VAWTER; C A JANEWAY; F S ROSEN
Journal:  N Engl J Med       Date:  1965-09-02       Impact factor: 91.245

3.  Quantitative determination of the serum globulins beta-2A and beta-2M by immunoelectrophoretic analysis.

Authors:  C D WEST; V HINRICHS; N H HINKLE
Journal:  J Lab Clin Med       Date:  1961-07

4.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

5.  Anti-nuclear factors and serum complement in systemic lupus erythematosus.

Authors:  J H MORSE; H J MULLER-EBERHARD; H G KUNKEL
Journal:  Bull N Y Acad Med       Date:  1962-10

6.  Antigenic determinants of human beta-1c and beta-1g-globulins.

Authors:  C West; N C Davis; J Forristal; J Herbst; R Spitzer
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

7.  Beta-1C-globulin: metabolism in glomerulonephritis.

Authors:  C A Alper; A S Levin; F S Rosen
Journal:  Science       Date:  1966-07-08       Impact factor: 47.728

8.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

  8 in total
  20 in total

1.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 2.  Complement and the kidney.

Authors:  D K Peters; D G Williams
Journal:  Proc R Soc Med       Date:  1972-12

3.  Effect of ageing of serum on consumption of antibody by beta-1C-globulin determinants; evidence for circulating breakdown products in glomerulonephritis.

Authors:  C D West; S Winter; J Forristal; N C Davis
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

4.  Immunoconglutinin and complement changes in children with acute nephritis.

Authors:  J L Ngu; J F Soothill
Journal:  Clin Exp Immunol       Date:  1969-12       Impact factor: 4.330

5.  Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia.

Authors:  N G Westberg; G B Naff; J T Boyer; A F Michael
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

6.  Glomerulonephritis: clinical aspects.

Authors:  D P Earle
Journal:  Bull N Y Acad Med       Date:  1970-10

7.  Serum complement and immunoconglutinin in malnutrition.

Authors:  R K Chandra
Journal:  Arch Dis Child       Date:  1975-03       Impact factor: 3.791

8.  Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

9.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  A case of active chronic hepatitis with painless erosive arthritis.

Authors:  D E Barnardo; B Vernon-Roberts; H L Currey
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.